These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Hall A, Bostanci A, Wright CF. Public Health Genomics; 2010 Apr; 13(4):246-55. PubMed ID: 20395693 [Abstract] [Full Text] [Related]
4. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology. J Clin Oncol; 2003 Jun 15; 21(12):2397-406. PubMed ID: 12692171 [Abstract] [Full Text] [Related]
5. Non-invasive prenatal genetic testing: a study of public attitudes. Kelly SE, Farrimond HR. Public Health Genomics; 2012 Jun 15; 15(2):73-81. PubMed ID: 22094262 [Abstract] [Full Text] [Related]
6. [Noninvasive prenatal genetic diagnosis: a bioethical reflection on the use of noninvasive prenatal diagnosis from the analysis of nucleic acids present in maternal peripheral blood]. González-Melado FJ, Di Pietro ML. Cuad Bioet; 2011 Jun 15; 22(74):49-75. PubMed ID: 21692554 [Abstract] [Full Text] [Related]
7. Prenatal screening: current practice, new developments, ethical challenges. de Jong A, Maya I, van Lith JM. Bioethics; 2015 Jan 15; 29(1):1-8. PubMed ID: 25521968 [Abstract] [Full Text] [Related]
8. Non-invasive prenatal diagnosis for aneuploidy: toward an integral ethical assessment. de Jong A, Dondorp WJ, Frints SG, de Die-Smulders CE, de Wert GM. Hum Reprod; 2011 Nov 15; 26(11):2915-7. PubMed ID: 21840907 [Abstract] [Full Text] [Related]
9. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Wright CF, Burton H. Hum Reprod Update; 2009 Nov 15; 15(1):139-51. PubMed ID: 18945714 [Abstract] [Full Text] [Related]
10. Ethical issues in ocular genetics. Mezer E, Wygnanski-Jaffe T. Curr Opin Ophthalmol; 2009 Sep 15; 20(5):382-6. PubMed ID: 19587598 [Abstract] [Full Text] [Related]
12. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues. Bailey DB, Skinner D, Davis AM, Whitmarsh I, Powell C. Pediatrics; 2008 Mar 15; 121(3):e693-704. PubMed ID: 18310190 [Abstract] [Full Text] [Related]
13. Genetic counseling and testing: implications for clinical practice. Johnson KA, Brensinger JD. Nurs Clin North Am; 2000 Sep 15; 35(3):615-26. PubMed ID: 10957677 [Abstract] [Full Text] [Related]
14. Key Ethical Issues in Prenatal Genetics: An Overview. Farrell RM, Allyse MA. Obstet Gynecol Clin North Am; 2018 Mar 15; 45(1):127-141. PubMed ID: 29428280 [Abstract] [Full Text] [Related]
15. Informed consent: attitudes, knowledge and information concerning prenatal examinations. Dahl K, Kesmodel U, Hvidman L, Olesen F. Acta Obstet Gynecol Scand; 2006 Mar 15; 85(12):1414-9. PubMed ID: 17260214 [Abstract] [Full Text] [Related]
16. Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues. Minear MA, Alessi S, Allyse M, Michie M, Chandrasekharan S. Annu Rev Genomics Hum Genet; 2015 Mar 15; 16():369-98. PubMed ID: 26322648 [Abstract] [Full Text] [Related]
17. [Non-invasive Genetic Prenatal Testing - A Serious Challenge for Society as a Whole]. Zerres K. Z Geburtshilfe Neonatol; 2015 Apr 15; 219(2):69-72. PubMed ID: 25901867 [Abstract] [Full Text] [Related]
18. [Ethical aspects of disclosing information on prenatal screening for Down's syndrome]. Tóth A, Szabó J. Orv Hetil; 2005 Feb 06; 146(6):259-65. PubMed ID: 15779814 [Abstract] [Full Text] [Related]
19. Cultural variation in values attached to informed choice in the context of prenatal diagnosis. van den Heuvel A, Marteau TM. Semin Fetal Neonatal Med; 2008 Apr 06; 13(2):99-102. PubMed ID: 18255366 [Abstract] [Full Text] [Related]
20. Prenatal carrier testing for fragile X: counseling issues and challenges. Musci TJ, Moyer K. Obstet Gynecol Clin North Am; 2010 Mar 06; 37(1):61-70, Table of Contents. PubMed ID: 20494258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]